<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40848897</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-4754</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Brain stimulation</Title><ISOAbbreviation>Brain Stimul</ISOAbbreviation></Journal><ArticleTitle>Transcranial direct current stimulation plus cognitive training for cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection: A randomized, double-blind, sham-controlled trial.</ArticleTitle><Pagination><StartPage>1608</StartPage><EndPage>1616</EndPage><MedlinePgn>1608-1616</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.brs.2025.08.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1935-861X(25)00311-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Post-acute sequelae of SARS-CoV-2 infection (PASC) is characterized by persistent cognitive deficits alongside anxiety and depression symptoms that adversely affect quality of life. Cognitive training (CT) programs and non-invasive neuromodulation, specifically transcranial direct current stimulation (tDCS), have each shown promise for alleviating similar deficits in non-clinical populations. However, their combined efficacy has not yet been evaluated in PASC patients. Therefore, this study aimed to determine whether the combination of CT and tDCS produces benefits for cognitive and mood-related symptoms in individuals with PASC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a double-blind, randomized, sham-controlled clinical trial in adults aged 18-75 with confirmed SARS-CoV-2 infection within the past six months and persisting cognitive complaints. They were randomized to a 4-week in-person intervention of 20 weekday sessions of either active (2&#xa0;mA anodal-left, cathodal-right prefrontal stimulation) or sham tDCS paired with an app-based CT program. Primary outcomes were six standardized neuropsychological tests assessing verbal memory, working memory, executive functioning, attention, and language, administered at baseline and immediately post-intervention. As secondary outcomes, we assessed changes in depression and anxiety symptoms over the treatment period.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty participants (mean age 43.8&#xa0;&#xb1;&#xa0;13.2 years, 71.7&#xa0;% women) were randomized to active tDCS&#xa0;+&#xa0;CT or sham tDCS&#xa0;+&#xa0;CT groups, and 52 finished the trial. Compared to sham, tDCS&#xa0;+&#xa0;CT resulted in significantly greater improvement in tests evaluating inhibitory control (effect size [ES]&#xa0;=&#xa0;0.07, 95&#xa0;% CI 0 to 0.23, p&#xa0;=&#xa0;0.046), processing speed (ES&#xa0;=&#xa0;0.08, 95&#xa0;% CI 0 to 0.25, p&#xa0;=&#xa0;0.034), and divided attention (ES&#xa0;=&#xa0;0.08, 95&#xa0;% CI 0 to 0.24, p&#xa0;=&#xa0;0.039), but not in tests evaluating other domains. Both groups improved similarly in depression and anxiety symptoms. Participant's and rater's active guess rates did not differ between groups (ps&#xa0;&gt;&#xa0;0.20).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">An intervention with prefrontal targeted tDCS&#xa0;+&#xa0;CT in patients with PASC with cognitive complaints might be effective in improving attention, processing speed and inhibitory control, although further studies are warranted to prospectively confirm these findings.</AbstractText><AbstractText Label="CLINICALTRIALS" NlmCategory="RESULTS">GOV: NCT05389592.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vidal</LastName><ForeName>Kallene Summer</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavendish</LastName><ForeName>Beatriz Ara&#xfa;jo</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goerigk</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, Ludwig-Maximilians Universit&#xe4;t, Nussbaumstra&#xdf;e 7, 80336 Munich, Germany; DZPG (German Center for Mental Health), Partner Site Augsburg, Munich-Germany; Charlotte Fresenius Hochschule, Infanteriestra&#xdf;e 11A, 80797 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pita Batista</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira Lima</LastName><ForeName>Alisson Rafael</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Bianca Silva</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neto Domingos</LastName><ForeName>Adriano Augusto</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Sousa</LastName><ForeName>Juliana Pereira</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosof</LastName><ForeName>Rebeca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertola</LastName><ForeName>Laiss</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Valquiria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suemoto</LastName><ForeName>Claudia Kimie</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Division of Geriatrics, University of Sao Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razza</LastName><ForeName>Lais Boralli</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>Department of Head and Skin, Psychiatry and Medical Psychology, Ghent University Hospital, Ghent University, Ghent, Belgium; Ghent Experimental Psychiatry Laboratory, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bikson</LastName><ForeName>Marom</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering. The City College of New York, New York, NY USA 10031.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pilloni</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, NYU Grossman School of Medicine, New York, NY USA 10017.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charvet</LastName><ForeName>Leigh</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, NYU Grossman School of Medicine, New York, NY USA 10017.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Pedro H R</ForeName><Initials>PHR</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunoni</LastName><ForeName>Andre R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S&#xe3;o Paulo Medical School, S&#xe3;o Paulo, Brazil; Department of Psychiatry and Peter O'Donnell Brain Institute, UT Southwestern Medical Center, Dallas (TX), USA. Electronic address: andre.russowskybrunoni@utsouthwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05389592</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Stimul</MedlineTA><NlmUniqueID>101465726</NlmUniqueID><ISSNLinking>1876-4754</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">Long-covid</Keyword><Keyword MajorTopicYN="N">Non-invasive brain stimulation</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">tDCS</Keyword></KeywordList><CoiStatement>Declaration of competing interest Soterix Medical Inc. provided the tDCS equipment for research use. The City University of New York has a patent on brain stimulation with MB as the inventor. MB has equity in Soterix Medical Inc. MB consults, received grants, assigned inventions, and/or serves on the SAB of SafeToddles, Boston Scientific, GlaxoSmithKline, Biovisics, Mecta, Lumenis, Halo Neuroscience, Google-X, i-Lumen, Humm, Allergan (Abbvie), Apple. No conflict of interest was declared by the other authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>24</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>24</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>23</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40848897</ArticleId><ArticleId IdType="doi">10.1016/j.brs.2025.08.018</ArticleId><ArticleId IdType="pii">S1935-861X(25)00311-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>